April 1st, 2015
No one doubts that the US spends more than any other country on health care. Whether this higher spending produces commensurate health benefits, however, is far from certain.
In the April 2012 issue of Health Affairs, Philipson et. al. make an intuitively persuasive observation, one which they summarize in their recent Health Affairs Blog post (authored by Goldman, Lakdawalla, and Philipson): “We find that survival after diagnosis rose more quickly in the U.S. than the E.U.”
Given this observation, they go on to make an inference, namely that the US gets value from it additional expenditures on cancer care. It would be nice were the world so simple. But it’s not.Read the rest of this entry »